Araştırma Makalesi
BibTex RIS Kaynak Göster

PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER

Yıl 2018, Cilt: 4 Sayı: 1, 1 - 5, 09.06.2018

Öz

Primary Adenocarcinoma of the bladder is uncommon histological variant of the transitional cell carcinoma and account 0.5% to 2.0% of all malignant vesical tumors.(1) It has an aggressive biological behavior and poor response to chemotherapy and radiotherapy. The only curative option is surgery-radical cystectomy or partial resection.(2)(4) To focus on the existence of rare histological subtype of the transitional cell carcinoma of the urinary bladder and to differ the primary from the secondary “  metastatic  ” adenocarcinoma. A 73 years old male with gross hematuria, anemia and renal failure.  Ultrasound and CT reveal solid, infiltrative tumor in the trigone with engagement to the left ureteric orifice and ureterohydronephrosis. histologic and immunohistochemical examination of the resected specimen showed primary bladder adenocarcinoma. No radical surgical treatment was performed because of the comorbidity and deteriorated general condition of the patient. We managed percutaneous nephrostomy with chemotherapy and radiotherapy. The malignant degeneration of the urothelium into the rare histological variant “ adenocarcinoma”arises many  questions. It is accepted that predisposition for adenocarcinoma exist in patients with bladder extrophy, in areas where infection with Schistosoma is endemic, chronic urine retention, cystitis(3) More common is the secondary “ metastatic” adenocarcinoma  from the digestive system and the genital system. This requires detailed clinical investigation of the patients and histologic and immunohistochemical examination of the resected tumor.(5),(6) A number of secondary "metastatic" adenocarcinomas are described such as urachus carcinoma, ring-cell carcinoma, hepatoid adenocarcinoma; metastatic prostate adenocarcinoma and mixed tumors.(7) Despite the scarcely information on rare histological variants of urothelial carcinoma of the urinary Bladder, there is sufficient evidence based on worldwide practice supporting the fact that histological and immunohistochemical subtyping of the tumor is essential in therapeutic and prognostic terms. Primary adenocarcinoma of the bladder is a rare neoplasia of the urothelium with aggressive biological behavior. Tumor is usually manifested in an advanced clinical stage. This limits surgical treatment options in partial resection or radical cystectomy with adjuvant chemotherapy or radiotherapy.  

Kaynakça

  • Bates, A.W. & Baithun, S.I. (2000)Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology, 36, 32–40. Bruno Mello R. Santos, Julia Duarte de Souza, * Rachel Silviano Brandão Correa Lima, and Enaldo Melo de Lima. (2015), Mucinous Bladder Adenocarcinoma: Case Report and Literature Review. Case Rep Urol. 783109. Epstein, J.I., Amin, M.B. & Reuter, V.E .(2010) Glandular lesions. In: Epstein JI, Amin MB, Reuter VE , eds. Bladder Biopsy Interpretation: Biopsy Interpretation Series. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins;150–176. Ghoneim, M.A., Abdel-Latif, M, El-Mekresh M, Abol-Enein, H., Mosbah A, Ashamallah, A. & El-Baz, M.A. (2008) Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years Later. J Urol.180:121–127. Melicow, M.M. (1995) Tumors of the urinary bladder: a clinicopathological analysis of over 2500 specimens and biopsies. The Journal of Urology. 7(4), 498-521 Shaaban, A.A., Elbaz, M.A. & Tribukait B. (1998) Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Am J Clin Exp Urol., 3(2): 51–63. Somak, R. & Anil V. P., (2011) Adenocarcinoma of the Urinary Bladder. Archives of Pathology & Laboratory Medicine: 135(12),1601-1605.
Yıl 2018, Cilt: 4 Sayı: 1, 1 - 5, 09.06.2018

Öz

Kaynakça

  • Bates, A.W. & Baithun, S.I. (2000)Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology, 36, 32–40. Bruno Mello R. Santos, Julia Duarte de Souza, * Rachel Silviano Brandão Correa Lima, and Enaldo Melo de Lima. (2015), Mucinous Bladder Adenocarcinoma: Case Report and Literature Review. Case Rep Urol. 783109. Epstein, J.I., Amin, M.B. & Reuter, V.E .(2010) Glandular lesions. In: Epstein JI, Amin MB, Reuter VE , eds. Bladder Biopsy Interpretation: Biopsy Interpretation Series. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins;150–176. Ghoneim, M.A., Abdel-Latif, M, El-Mekresh M, Abol-Enein, H., Mosbah A, Ashamallah, A. & El-Baz, M.A. (2008) Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years Later. J Urol.180:121–127. Melicow, M.M. (1995) Tumors of the urinary bladder: a clinicopathological analysis of over 2500 specimens and biopsies. The Journal of Urology. 7(4), 498-521 Shaaban, A.A., Elbaz, M.A. & Tribukait B. (1998) Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Am J Clin Exp Urol., 3(2): 51–63. Somak, R. & Anil V. P., (2011) Adenocarcinoma of the Urinary Bladder. Archives of Pathology & Laboratory Medicine: 135(12),1601-1605.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Araştırma Makalesi
Yazarlar

M. Kadim Bu kişi benim

İ Delchev Bu kişi benim

St Zdravchev Bu kişi benim

V Peev Bu kişi benim

K Apti Bu kişi benim

M Gulanets Bu kişi benim

G Ivanoc Bu kişi benim

Yayımlanma Tarihi 9 Haziran 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 4 Sayı: 1

Kaynak Göster

APA Kadim, M., Delchev, İ., Zdravchev, S., Peev, V., vd. (2018). PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER. International Journal of Health Administration and Education Congress (Sanitas Magisterium), 4(1), 1-5.
AMA Kadim M, Delchev İ, Zdravchev S, Peev V, Apti K, Gulanets M, Ivanoc G. PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER. Sanitas magisterium. Haziran 2018;4(1):1-5.
Chicago Kadim, M., İ Delchev, St Zdravchev, V Peev, K Apti, M Gulanets, ve G Ivanoc. “PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER”. International Journal of Health Administration and Education Congress (Sanitas Magisterium) 4, sy. 1 (Haziran 2018): 1-5.
EndNote Kadim M, Delchev İ, Zdravchev S, Peev V, Apti K, Gulanets M, Ivanoc G (01 Haziran 2018) PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER. International Journal of Health Administration and Education Congress (Sanitas Magisterium) 4 1 1–5.
IEEE M. Kadim, İ. Delchev, S. Zdravchev, V. Peev, K. Apti, M. Gulanets, ve G. Ivanoc, “PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER”, Sanitas magisterium, c. 4, sy. 1, ss. 1–5, 2018.
ISNAD Kadim, M. vd. “PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER”. International Journal of Health Administration and Education Congress (Sanitas Magisterium) 4/1 (Haziran 2018), 1-5.
JAMA Kadim M, Delchev İ, Zdravchev S, Peev V, Apti K, Gulanets M, Ivanoc G. PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER. Sanitas magisterium. 2018;4:1–5.
MLA Kadim, M. vd. “PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER”. International Journal of Health Administration and Education Congress (Sanitas Magisterium), c. 4, sy. 1, 2018, ss. 1-5.
Vancouver Kadim M, Delchev İ, Zdravchev S, Peev V, Apti K, Gulanets M, Ivanoc G. PRIMARY ADENOCARCINOMA OF THE URINARY BLADDER. Sanitas magisterium. 2018;4(1):1-5.

https://dergipark.org.tr/tr/download/journal-file/2143321433